OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Investigation into the effect and mechanism of dapagliflozin against renal interstitial fibrosis based on transcriptome and network pharmacology
Yuyuan Liu, Yanzhe Wang, Sijia Chen, et al.
International Immunopharmacology (2022) Vol. 112, pp. 109195-109195
Closed Access | Times Cited: 11
Yuyuan Liu, Yanzhe Wang, Sijia Chen, et al.
International Immunopharmacology (2022) Vol. 112, pp. 109195-109195
Closed Access | Times Cited: 11
Showing 11 citing articles:
Dapagliflozin alleviates renal fibrosis in a mouse model of adenine-induced renal injury by inhibiting TGF-β1/MAPK mediated mitochondrial damage
Jianhua Zeng, Hao Huang, Yan Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Jianhua Zeng, Hao Huang, Yan Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Vitamin A and retinoid signaling in the kidneys
Krysta M. DiKun, Lorraine J. Gudas
Pharmacology & Therapeutics (2023) Vol. 248, pp. 108481-108481
Closed Access | Times Cited: 11
Krysta M. DiKun, Lorraine J. Gudas
Pharmacology & Therapeutics (2023) Vol. 248, pp. 108481-108481
Closed Access | Times Cited: 11
Sodium-Glucose Co-Transporter 2 Inhibitors: Mechanism of Action and Efficacy in Non-Diabetic Kidney Disease from Bench to Bed-Side
Aly M. Abdelrahman, Alaa S. Awad, Emaad M. Abdel‐Rahman
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 956-956
Open Access | Times Cited: 4
Aly M. Abdelrahman, Alaa S. Awad, Emaad M. Abdel‐Rahman
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 956-956
Open Access | Times Cited: 4
Integrated Omics Insights into Dapagliflozin Effects in Sepsis-Induced Cardiomyopathy
Weiwei Lai, Li Liu, Shuhang Wang, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 286-286
Open Access
Weiwei Lai, Li Liu, Shuhang Wang, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 286-286
Open Access
Repurposing Secukinumab and Dapagliflozin as Candidate Therapies to Mitigate the Renal Toxicity of Sunitinib in Rats Through Suppressing IL‐17‐Mediated Pyroptosis and Promoting Autophagy
Rania A. Elrashidy, Hoda E. Mohamad, Sara M. Abdel Aal, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 3
Closed Access
Rania A. Elrashidy, Hoda E. Mohamad, Sara M. Abdel Aal, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 3
Closed Access
Dapagliflozin ameliorates kidney injury following limb ischemia-reperfusion via the AMPK/SIRT1/NLRP3 pathway
Qiuxiao Zhu, Huiyao Hao, Ya Gao, et al.
Renal Failure (2025) Vol. 47, Iss. 1
Open Access
Qiuxiao Zhu, Huiyao Hao, Ya Gao, et al.
Renal Failure (2025) Vol. 47, Iss. 1
Open Access
The protective mechanism of Dehydromiltirone in diabetic kidney disease is revealed through network pharmacology and experimental validation
Yanzhe Wang, Yuyuan Liu, Sijia Chen, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Yanzhe Wang, Yuyuan Liu, Sijia Chen, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Sodium Glucose Co-transporter 2 Inhibitors: Pharmacology, Mechanism of Action and Efficacy in Non-diabetic Kidney Disease from Bench to Bed-Side
Aly M. Abdelrahman, Alaa S. Awad, Emaad M. Abdel‐Rahman
(2024)
Open Access | Times Cited: 1
Aly M. Abdelrahman, Alaa S. Awad, Emaad M. Abdel‐Rahman
(2024)
Open Access | Times Cited: 1
Glutamate ionotropic receptor NMDA type subunit 1: A novel potential protein target of dapagliflozin against renal interstitial fibrosis
Yuyuan Liu, Yanzhe Wang, Sijia Chen, et al.
European Journal of Pharmacology (2023) Vol. 943, pp. 175556-175556
Closed Access | Times Cited: 3
Yuyuan Liu, Yanzhe Wang, Sijia Chen, et al.
European Journal of Pharmacology (2023) Vol. 943, pp. 175556-175556
Closed Access | Times Cited: 3
Soluble Prorenin Receptor: A Novel Biomarker for the Prediction of Renal Interstitial Fibrosis and Chronic Kidney Disease
Xiaojie Ye, Jiachun Xu, Ye Zhu, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Xiaojie Ye, Jiachun Xu, Ye Zhu, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Dapagliflozin: A new hope for the therapeutic treatment of type 2 diabetes mellitus
Naazneen Maksud, Sidhant Bera, Mohd. Javed Naim, et al.
European Journal of Medicinal Chemistry Reports (2024) Vol. 11, pp. 100167-100167
Open Access
Naazneen Maksud, Sidhant Bera, Mohd. Javed Naim, et al.
European Journal of Medicinal Chemistry Reports (2024) Vol. 11, pp. 100167-100167
Open Access
